Timothy J. Scannell, Director at NovoCure Ltd (NVCR), sold 964 shares at $23.89 ($23K) on 2024-06-04, disclosed to the SEC on 2024-06-06.
Open-market sale of $23k NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PODD | SELL | 2024-09-11 | $1.1M | — | Filing → |
| PODD | SELL | 2024-06-11 | $1.3M | — | Filing → |
| PODD | SELL | 2024-05-29 | $597K | — | Filing → |